Cancer

In the relentless battle against non-small cell lung cancer (NSCLC), targeted treatments such as epidermal growth factor receptor tyrosine kinase...

In a compelling new case report published in the March 2026 issue of Oncoscience, researchers present a diagnostically perplexing manifestation...

At the forefront of cancer innovation, researchers from Memorial Sloan Kettering Cancer Center (MSK) showcased groundbreaking advancements at the 2026...

In a groundbreaking study published in the prestigious journal Cancer Research on April 22, 2026, researchers at St. Jude Children’s...

Wayne State University and the Barbara Ann Karmanos Cancer Institute have launched a pioneering initiative to tackle cancer disparities exacerbated...

A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer...

In a groundbreaking advancement for the treatment of large B-cell lymphoma (LBCL), researchers have demonstrated that metabolic tumor volume (MTV),...

A groundbreaking study published in the Journal of the American College of Cardiology (JACC) has brought to light crucial insights...

A groundbreaking study spearheaded by Henry Daniell and his team at the University of Pennsylvania’s School of Dental Medicine has...

New research from the University of Toronto and the University Health Network shines a piercing light on the enduring shadows...

In a landmark study published on April 22, 2026, researchers have shed significant light on a contentious surgical debate pivotal...

Gamma delta (γδ) T cells represent an intriguing subset of the immune system that has garnered increasing attention for their...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by empowering the immune system to recognize and attack tumor cells. However,...

Researchers at Memorial Sloan Kettering Cancer Center have unveiled pivotal insights into the earliest stages of tumor formation in lung...

Immune checkpoint inhibitors (ICIs) have ushered in a new era in oncology, transforming the therapeutic landscape for a variety of...

In recent years, the landscape of muscle-invasive bladder cancer (MIBC) treatment has undergone a profound transformation, propelled by advances in...

Hepatocellular carcinoma (HCC) remains one of the deadliest cancer types globally, accounting for substantial cancer-related mortality despite ongoing advances in...

In a groundbreaking study published recently in the British Journal of Cancer, researchers from an international consortium have shed new...

A groundbreaking advancement in the treatment of muscle-invasive bladder cancer has emerged from recent clinical research at NYU Langone Health’s...

A groundbreaking study published in Nature Communications reveals a complex and mutually beneficial relationship between two bacterial species in the...